Analyst Ratings for Trillium Therapeutics (TRIL)

TRIL Rating Summary

TRIL Price Target Summary

* Over Last 12-Mos
  |   Expand Research on TRIL
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $17.00 (+74.5%) * Over Last 12-Mos
Rating Score: 9 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/14/2021 Benchmark N/A New Coverage Buy
(N/A)
N/A
(N/A)
10.08
(9.74)
-3.37% Details
10/12/2020 Evercore ISI N/A New Coverage Outperform
(N/A)
N/A
(N/A)
15.37
(9.74)
-36.63% Details
Like TRIL Ratings? Also take a look at PFE, PHAT, PASG, FIXX

TRIL Ratings News